ObjectiveTo observe the effect of donor liver pretreated by breviscapine on liver transplantation ischemia/reperfusion injury in rats. Methods SD rats served as liver donors and recipients (n =48 each).The recipients were divided into four groups by random number table.The donors in groups A and C were not pretreated with breviscapine,but those in groups B and D were pretreated with 20 mg/L Breviscapine.The cold ischemia time in donor livers of groups A and B was 30-40 min,and that in groups C and D was 12 h. Clotting function, liver function, serum thrombomodulin,caspase3,and relative activity of NF-kB after liver transplantation were assessed,and the pathological changes and TUNEL apoptosis staining were observed.ResultsThe mortality in groups C and D was 40.0％ (8/20) and 29.4％ (5/17),respectively (P＞0.05).There were no significant changes in coagulation function in all groups after operation. The liver function was improved,pathological lesions were alleviated,and apoptosis rate,serum TM,caspase3 expression and activity of NF-kB in the liver tissues of group D were significantly decreased as compared with group C at 3rd day after operation (P＜0.01),but all these parameters in group B had no significant change compared to group A.ConclusionPretreatment of donor livers with breviscapine can reduce the ischemia/reperfusion injury and apoptosis after liver transplantation in rats probably by inhibiting the apoptosis-related pathway and alleviating the damage to the endothelial cells of the liver microcirculation.

Objective To conduct cloning, sequencing and expression of Trichinella spiralis ES antigen p49 gene. Methods RT-PCR was used to amplify the specific gene fragment from the total RNA of Trichinella spirais larvae. The PCR product was ligated to the T-vector and the recombinant plasmid was verified by sequencing. T-p49 and pGE-4T-3 were treated by both BamHI and XhoI. The ligation reaction was catalyzed by T4 DNA ligase. Results The p49 gene was cloned by using RT-PCR. Sequence analysis showed that the p49 gene obtained was consistent to the p49 sequence reported in the database. The expressed protein was shown as a new band at SDS-PAGE. BLAST analysis demonstrated that this p49 gene was 99% identical to the p49 gene reported and to the 43 kDa secreted glycoprotein gene in the database. Conclusion p49 gene from Trichinella spiralis larvae was cloned, sequenced and expressed.

Objective:To evaluate the efficacy and safety of periarticular cocktail injection analgesia after arthroscopic rotator cuff repair surgery.Methods:From June 2020 to May 2021, 120 patients with rotator cuff tears were treated at Shandong University Qilu Hospital (Qingdao) with arthroscopic rotator cuff repair surgery. The cohort included 45 males and 75 females, aged 61.35±5.75 years (range 57-67 years), with 58 cases involving the left shoulder joint and 62 cases involving the right shoulder joint. Patients were randomly divided into a cocktail group (receiving periarticular injections of ropivacaine, morphine, adrenaline, and compound betamethasone) and an analgesic pump group (using an analgesic pump). Standardized protocols were used for perioperative and postoperative analgesia. The visual analog scale (VAS) of pain and shoulder joint range of motion were recorded on the day of surgery, the first and second postoperative days, the day of discharge, and at follow-up at 2 and 6 weeks. The postoperative demand for temporary analgesics (celecoxib), as well as adverse reactions to cocktail injections and analgesic pump applications were also recorded.Results:There were no statistically significant differences in age, gender, surgical time, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, preoperative VAS score, surgical time, postoperative hospital stay, rotator cuff tear area, and intraoperative anchor number between the two groups of patients ( P>0.05). Patients who received periarticular cocktail injections performed better in terms of postoperative VAS scores and functional recovery. Compared with the analgesic pump group, the temporary use of analgesics in the cocktail group was significantly reduced at 6, 12, and 24 hours after surgery. After 12 hours of surgery, the cocktail group received 3(3, 4) points and the analgesic pump group received 5(5, 6) points, with statistically significant differences ( Z=143.004, P=0.003); 18 hours after surgery, the VAS score in the cocktail group showed a rebound, rising to 4(3, 4) points, but still lower than 5(4, 5) points in the analgesic pump group. There was no significant difference in VAS scores between the cocktail group and the analgesic pump group at 24-48 hours after surgery ( P>0.05). The use of cocktail injections was associated with lower VAS scores at 12 hours post-surgery ( OR=4.125; 95% CI: 2.672, 4.328; P=0.015). There is no correlation between age, BM, ASA, pre-operative VAS, surgical time, rotator cuff tear size, number of anchor bolts used, and postoperative VAS score at 12 hours. Multivariate regression analysis of postoperative 24-hour VAS scores showed that no factors were associated with postoperative 24-hour VAS scores. Conclusion:Periarticular cocktail injection can significantly reduce the need for postoperative pain relief and improve patient satisfaction, without posing significant risks after arthroscopic rotator cuff repair surgery.